NIH-funded research R01 grant

Improving cognitive function in psychotic disorders by targeting a specific protein

Official title: Targeting Arc to Improve Cognitive Deficits in Psychotic Disorders

Funded at Massachusetts General Hospital · NIH-11134697 · Data updated 2026-11-12

This study is looking at how a protein called Arc affects thinking problems in people with conditions like schizophrenia, and it aims to find new treatments that could help improve memory and cognitive skills for those who struggle with these issues.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startJuly 8, 2024
Project endFebruary 28, 2029
Funding year2025
Award (this year)$701,254
NIH project number5R01MH134923-02
Project IDNIH-11134697 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults diagnosed with schizophrenia or related psychotic disorders who experience cognitive deficits.

Less likely to help

Patients with psychotic disorders who do not exhibit cognitive impairments may not benefit from this research.

What this research studies

This research investigates the role of the Arc protein complex in cognitive impairments associated with psychotic disorders like schizophrenia. By using advanced screening techniques on mouse neurons, the study aims to identify small molecules that can enhance the expression of Arc, which is believed to be crucial for cognitive function. One promising candidate, the atypical antipsychotic lurasidone, has shown potential in improving cognitive performance in clinical settings. The goal is to explore whether targeting Arc can lead to better treatment options for cognitive deficits in patients with these disorders.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that significantly improve cognitive function in individuals with psychotic disorders.

How similar studies have gone: Previous studies have shown that targeting similar pathways can lead to improvements in cognitive function, suggesting a promising avenue for this research.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Karmacharya, Rakesh — Massachusetts General Hospital
  • Study coordinator: Karmacharya, Rakesh

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.